Back to top
more

Phibro Animal Health (PAHC)

(Delayed Data from NSDQ)

$22.01 USD

22.01
388,437

+1.12 (5.36%)

Updated Oct 8, 2024 04:00 PM ET

After-Market: $22.00 -0.01 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (67 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Why Is Phibro (PAHC) Down 13.3% Since Last Earnings Report?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Here's Why You Should Invest in Phibro (PAHC) Right Now

    Phibro (PAHC) sees improvement across all segments. The Animal Health business has been a key contributor.

      Phibro Animal (PAHC) Q4 Earnings Beat, Sales Improve Y/Y

      Phibro (PAHC) witnesses year-over-year improvement across all segments in Q4.

        Why Is Phibro Animal (PAHC) Up 10.7% Since Its Last Earnings Report?

        Phibro Animal (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

          Phibro Animal (PAHC) Q3 Earnings Beat, Sales Improve Y/Y

          Phibro (PAHC) witnesses year-over-year improvement across all segments in Q3.

            Zacks.com featured highlights include: Archer Daniels, Phibro Animal, NEXEO, Western Digital and Fortinet

            Zacks.com featured highlights include: Archer Daniels, Phibro Animal, NEXEO, Western Digital and Fortinet

              5 Stocks Near 52-Week High: Is More Upside Left?

              These stocks have passed through a screen we ran to find those that are trading near their 52-week high levels and still have plenty of upside left.

                Here's Why Phibro Animal Health is Worth a Buy Right Now

                Phibro Animal Health (PAHC) continues to boost investor confidence on the back of sturdy segmental performances.

                  5 Growth Stocks in MedTech Set to Scale Higher in 2018

                  The U.S. MedTech markets have been riding high with merger and acquisitions in focus.

                    Phibro Animal Health (PAHC) Up 7% Since Earnings Report: Can It Continue?

                    Phibro Animal Health (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                      Phibro Animal (PAHC) Beats on Q2 Earnings, Raises Guidance

                      Phibro (PAHC) witnesses year-over-year improvement across all segments in Q2.

                        Should You Sell Phibro Animal Health (PAHC) Before Earnings?

                        Given that Phibro Animal Health (PAHC) has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings.

                          Phibro (PAHC) Strong on Animal Health Arm, Dull MFA Ails

                          Phibro's (PAHC) Animal Health segment has been a key contributor to growth over the last few quarters. MFA remains soft in the United States due to sales decline of medically important antimicrobials.

                            Dull MFA & Mineral Nutrition Sales Hurt Phirbo, Rivalry Rife

                            Phibro's (PAHC) Medicated feed additives (MFA) business was weak in the United States. Also, a persistent decline in Mineral Nutrition segment sales is likely to raise concern.

                              Phibro Animal (PAHC) Beats on Q1 Earnings, Reiterates View

                              Phibro Animal (PAHC) witnesses year-over-year improvement across all segments in Q1.

                                Phibro Animal Banks on Diverse Portfolio, Competition Rife

                                Phibro Animal (PAHC) is consistently trying to expand its product portfolio to counter the tough competition in the animal health space.

                                  Phibro (PAHC) Down 2.7% Since Earnings Report: Can It Continue?

                                  Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                    Phibro Animal Health Expands Globally Amid Tough Competition

                                    Phibro (PAHC) is consistently trying to expand globally to counter the tough competition in the animal health and mineral nutrition space.

                                      Phibro Animal (PAHC) Beats Q4 Earnings & Sales Estimates

                                      Phibro Animal (PAHC) reported solid fourth-quarter fiscal 2017 revenues on the back of sales growth in the Animal Health, Mineral Nutrition and Performance Products segments.

                                        Phibro Animal Health & Zydus Cadila Plan to Expand in India

                                        Phibro Animal Health Corporation (PAHC) recently announced plans to enter into a long-term agreement with global pharmaceutical company Zydus Cadila to expand in the rapidly growing poultry market in India.

                                          Health Care Battle Rages On: 2 MedTech Stocks to Buy

                                          Let's focus on two MedTech Stocks which are fundamentally strong amidst the volatile market condition.

                                            Here's Why Phibro Animal Health Is Worth Buying Right Now

                                            Phibro Animal Health Corporation (PAHC), has rallied 24.2% over the past three months, ahead of the S&P 500's mere 2.6% gain.

                                              Phibro Animal Health (PAHC) Rides High on Solid Prospects

                                              On Jun 12, we issued an updated research report on NJ-based Phibro Animal Health Corporation (PAHC) ??? a leading global diversified animal health and mineral nutrition company.

                                                Phibro Animal Health (PAHC) Up 10% Since Earnings Report: Can It Continue?

                                                Phibro Animal Health (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                                  Can The Uptrend Continue for Phibro Animal Health (PAHC)?

                                                  Investors certainly have to be happy with Phibro Animal Health Corp (PAHC) and its short term performance